medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 2

<< Back Next >>

salud publica mex 2020; 62 (2)

Evaluation of Mexico’s low cancer mortality using two national death registries

Lozano-Esparza S, Stern D, Hernández-Ávila JE, Morales-Carmona E, Mohar A, Lajous M

Language: English
References: 16
Page: 181-185
PDF size: 226.84 Kb.


ABSTRACT

Objective. To compare cancer mortality rates in Mexico from two national death registries that independently code and attribute cause of death. Materials and methods. We compared 5-year age-standardized total cancer and sitespecific cancer mortality rates (2010-2014) from Mexico’s official death registry with a death registry from a disease surveillance system. We obtained age-adjusted mortality rates and 95% confidence intervals using the direct method and World Population Prospects 2010 as a standard. Results. Cancer mortality estimates for Mexico were minimally affected by the use of two distinct death certificate-coding procedures. Cancer mortality was 73.3 for Instituto Nacional de Estadística y Geografía and 72.7 for System for Epidemiologic Death Statistics per 100 000 women. The corresponding estimates for men were 68.3 and 67.8. Conclusion. Mexico’s low cancer mortality is unlikely to be explained by death certificate processing. Further investigations into the process of death certification and cancer registration should be conducted in Mexico.


REFERENCES

  1. Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013 [cited 2017 Dic]. Available from: http://gco.iarc. fr/today/online-analysis-table?v=2018&mode=population&mode_populat ion=countries&population=900&populations=900&key=asr&sex=0&can cer=39&type=1&statistic=5&prevalence=0&population_group=0&ages_ group%5B%5D=0&ages_group%5B%5D=17&nb_items=5&group_ cancer=1&include_nmsc=1&include_nmsc_other=1

  2. Institute for Health Metrics and Evaluation. Global Burden of Disease [internet site] Seattle: University of Washington, 2015 [cited 2017 Dic]. Available from: http://ghdx.healthdata.org/gbd-results-tool

  3. Angel JL, Vega W, Lopez-Ortega M. Aging in Mexico: Population trends and emerging issues. Gerontologist. 2016;57(2):153-62. https://doi. org/10.1093/geront/gnw136

  4. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S, et al. Characterizing the epidemiological transition in Mexico: National and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008;5(6):e125. https://doi.org/10.1371/journal.pmed.0050125

  5. Reynoso-Noveron N, Villarreal-Garza C, Soto-Perez-de-Celis E, ArceSalinas C, Matus-Santos J, Ramirez-Ugalde MT, et al. Clinical and epidemiological profile of breast cancer in Mexico: Results of the Seguro Popular. J Glob Oncol. 2017;3(6):757-64. https://doi.org/10.1200/JGO.2016.007377

  6. De Carvalho MH, Alvarez-Hernandez G, Denman C, Harlow SD. Validity of underlying cause of death statistics in Hermosillo, Mexico. Salud Publica Mex. 2011;53(4):312-9. https://doi.org/10.1590/S0036- 36342011000400005

  7. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision.Geneva:WHO, 2010 [cited 2017 Dic]. Available from: https://www.who.int/classifications/icd/ ICD10Volume2_en_2010.pdf

  8. National Center for Health Statistics. About the Mortality Medical Data System [internet]. Centers for Disease Control and Prevention, 2015 [cited 2017 Dic]. Available from: https://www.cdc.gov/nchs/nvss/mmds/ about_mmds.htm

  9. Department of Economic and Social Affairs, Population Division. World population prospects: the 2010 revision [internet]. United Nations Organization, 2013 [cited 2017 dic]. Available from: https://www.un.org/ en/development/desa/population/publications/pdf/trends/WPP2010/ WPP2010_Volume-I_Comprehensive-Tables.pdf

  10. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray C. Measuring the global burden of disease and risk factors. In: Lopez AD, Mathers CD, Ezzati M, et al., editors. Washington (DC): The International Bank for Reconstruction and Development/The World Bank, 2006 [cited 2017 Dic]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11817/

  11. Hernandez B, Ramirez-Villalobos D, Romero M, Gomez S, Atkinson C, Lozano R. Assessing quality of medical death certification: Concordance between gold standard diagnosis and underlying cause of death in selected Mexican hospitals. Popul Health Metr. 2011;9:38. https://doi. org/10.1186/1478-7954-9-38

  12. George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Glob Health. 2017;2(2):e000256. https:// doi.org/10.1136/bmjgh-2016-000256

  13. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: An assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171-7. https://doi.org/ S0042-96862005000300009

  14. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando-Hernández S, Hernández-Ávila M, Sepúlveda-Amor J. Encuesta Nacional de Salud y Nutrición 2006. Mexico: Instituto Nacional de Salud Pública, 2006. 2006 [cited 2017 Dic]. Available from: https://www.insp.mx/ images/stories/Produccion/pdf/100722_cp3.pdf

  15. Bright K, Barghash M, Donach M, de la Barrera MG, Schneider RJ, Formenti SC. The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico. Breast. 2011;20(suppl 2):S54-9. https://doi.org/10.1016/j.breast.2011.02.012

  16. Juarez-Cruz A. Motivos religiosos y el decremento de la autopsia en México. Implicaciones Bioéticas [Dissertation on the Internet]. Mexico City: Instituto Politécnico Nacional, 2007 [cited 2017 Dic]. Available from: https://tesis.ipn.mx/bitstream/handle/123456789/1819/1702_2007_ESM_ MAESTRIA_juarez_cruz_alfredo.pdf?sequence=1&isAllowed=y




2020     |     www.medigraphic.com